Tata Memorial Centre to get Rs 380 crore NSE funding for cancer facility

Rumela Sarkar

Tata Memorial Centre to get Rs 380 crore NSE funding for cancer facility

Written By : Rumela Sarkar Published On 2025-10-08T11:32:59+05:30 | Updated On 8 Oct 2025 11:32 AM IST

Mumbai to Get Nation’s Biggest Bone Marrow Transplant Centre by 2027

Mumbai: The Tata Memorial Centre’s Advanced Centre for Treatment, Research and Education in Cancer (ACTREC) in Kharghar is set to host the country’s largest bone marrow transplant (BMT) facility. The 60-bed centre will be constructed with Rs 380 crore Corporate Social Responsibility (CSR) contribution from the National Stock Exchange (NSE).

The upcoming 11-storey facility, to be named the NSE Multispecialty Hospital Block & Bone Marrow Transplant Cancer Hospital, will be constructed by Larsen & Toubro (L&T). A bhoomipujan ceremony was held on Sunday to mark the beginning of the project. Once construction is completed, the building will be officially handed over to ACTREC.

Also Read:Maharashtra approves MAHACARE Foundation to revolutionize cancer care

Speaking to TOI, ACTREC director Dr Pankaj Chaturvedi said, "At present, we have a five-bed BMT centre at ACTREC. Once the 60-bed building is complete, we will be able to perform 600 bone marrow transplants every year." The new facility, which is likely to commence operations by July 2027, will also be able to carry out 1.3 lakh outpatient department consultations annually.

ACTREC currently performs over 100 bone marrow transplants each year and treats more than 300 patients daily. It also pioneered indigenous CAR-T cell therapy for blood cancer in India in 2021.

Dr. Chaturvedi noted that the bone marrow transplants performed at the new facility would be the most affordable in the country. While BMTs can cost over Rs 40 lakh at some private hospitals and more than Rs 10 lakh even in public institutions, the Tata Memorial Centre supports families by helping them raise funds through donations.

The bhoomipujan ceremony was attended by key dignitaries, including Ashishkumar Chauhan, MD and CEO of NSE; Dr. Sudeep Gupta, Director, Tata Memorial Centre; Dr. Pankaj Chaturvedi, Director, ACTREC; and Dr. Navin Khattry, Deputy Director, ACTREC and Head of the BMT program.

Also Read:Tata Memorial Centre inks MoU with Powergrid for Digital Subtraction Angiography System

According to TOI, "This collaboration represents a major step toward bridging the gap in affordable, high-quality cancer care across India, bringing critical treatment access to thousands in need," said the NSE release.

Bone marrowcancer treatmentbone marrow transplantTata Memorial Center

Rumela Sarkar

With a keen interest in storytelling and a dedication to uncovering facts, Rumela De Sarkar joined Medical Dialogues as a Correspondent in 2024. She holds a Bachelor’s degree in English Literature from the University of North Bengal. Rumela covers a wide range of healthcare topics, including medical news, policy updates, and developments related to doctors, hospitals, and medical education